Women with early breast cancer to be tested for trastuzumab treatment.
作者信息
Mayor Susan
出版信息
BMJ. 2005 Oct 15;331(7521):864. doi: 10.1136/bmj.331.7521.864.
Abstract
摘要
相似文献
1
Women with early breast cancer to be tested for trastuzumab treatment.
BMJ. 2005 Oct 15;331(7521):864. doi: 10.1136/bmj.331.7521.864.
2
Sucked into the Herceptin maelstrom.
BMJ. 2007 Jan 6;334(7583):18. doi: 10.1136/bmj.39080.481551.47.
3
Herceptin: HERalding a new era in breast cancer care but at what cost?
Nat Clin Pract Oncol. 2005 Dec;2(12):595. doi: 10.1038/ncponc0378.
4
Trastuzumab for early breast cancer.
Lancet. 2006 Jan 14;367(9505):107. doi: 10.1016/S0140-6736(06)67951-8.
5
Herceptin and early breast cancer: a moment for caution.
Lancet. 2005 Nov 12;366(9498):1673. doi: 10.1016/S0140-6736(05)67670-2.
6
A "bureausceptic" view of cancer drug rationing.
Lancet. 2001 Nov 17;358(9294):1660. doi: 10.1016/S0140-6736(01)06726-5.
7
Patient takes her fight for trastuzumab to the High Court.
BMJ. 2006 Feb 11;332(7537):320. doi: 10.1136/bmj.332.7537.320-a.
8
Breast Cancer Advocacy Coalition responds to the 'Herceptin or deception' article.
N Z Med J. 2006 Jul 7;119(1237):U2065; author reply U2065.
9
The clinical effectiveness of trastuzumab for breast cancer: a systematic review.
Health Technol Assess. 2002;6(13):1-71. doi: 10.3310/hta6130.
10
Trastuzumab for early breast cancer: evolution or revolution?
Lancet Oncol. 2006 Jan;7(1):22-3. doi: 10.1016/s1470-2045(05)70533-7.
引用本文的文献
1
Depoliticisation, Resilience and the Herceptin Post-Code Lottery Crisis: Holding Back the Tide.
Br J Polit Int Relat. 2015 Nov;17(4):644-664. doi: 10.1111/1467-856X.12060.
2
Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.
Drugs. 2006;66(4):449-75. doi: 10.2165/00003495-200666040-00005.
3
Trastuzumab for early breast cancer raises important issues.
BMJ. 2005 Oct 29;331(7523):1023. doi: 10.1136/bmj.331.7523.1023-a.
Zotero 插件